Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

N-[4-(3-amino-1H-indazol-4-yl)phenyl]-Nī-(2-fluoro-5-methylphenyl) urea

EU orphan designation number: EU/3/07/517   
Active ingredient: N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N´-(2-fluoro-5-methylphenyl) urea
Indication: Treatment of hepatocellular carcinoma
Sponsor: AbbVie Ltd
Maidenhead, SL6 4UB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/12/2007 Orphan designation EMEA/OD/090/07 (2007)6812 of 20/12/2007
08/02/2013 Transfer of orphan designation EMA/OD/090/07/T/01 (2013)732 of 06/02/2013